MYTEMP - A study to determine if a cooler, personalized dialysis temperature prevents heart attacks, strokes and death!Published Fri Jun 17th 2016
The Department of Medicine congratulates Dr. Eduard Iliescu, Associate Professor, Division of Nephrology on the recent announcement by the Heart and Stroke Foundation of Canada (HSFC) of a $256, 440 Grant entitled - "Major Cardiovascular outcomes with personalized dialYsate TEMPerature (MY TEMP) - A registry-based cluster randomized controlled trial".
Dr. Iliescu explained about this recent grant from the Heart and Stroke Foundation of Canada:
"Dialysis is a life-sustaining therapy for people with kidney failure but one fifth die within 12 months of starting dialysis commonly from heart disease or stroke thought to be in part caused by low blood pressure which reduces the delivery oxygen to the heat and brain. Lowering the temperature of dialysis may prevent low blood pressure and preserve the flow of blood and oxygen to these organs.
This study aims to determine if a cooler, personalized dialysis temperature prevents heart attacks, strokes, and death.
It is a randomized controlled trial of 7500 dialysis patients in 82 clinics in Ontario. It is called MYTEMP. One group will get the standard temperature of 36.5ºC and the other group will get cooler, personalized dialysis (0.5ºC below their body temperature). The study is expected to start in April 2017. After 2 years the number of heart attacks, strokes and deaths will be compared among the groups. It is expected that this intervention may prevent up to 200 (10%) deaths or hospital admissions among dialysis patients in Ontario each year.
The study is supported in part by a grant from The Heart and Stroke Foundation of Canada. It is strongly endorsed by The Ontario Renal Network."